Cargando…
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
The COVID‐19 pandemic rapidly spread around the world following the first reports in Wuhan City, China in late 2019. The disease, caused by the novel SARS‐CoV‐2 virus, is primarily a respiratory condition that can affect numerous other bodily systems including the cardiovascular and gastrointestinal...
Autores principales: | John, Alison E., Joseph, Chitra, Jenkins, Gisli, Tatler, Amanda L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237078/ https://www.ncbi.nlm.nih.gov/pubmed/34028807 http://dx.doi.org/10.1111/imr.12977 |
Ejemplares similares
-
Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in ex vivo precision-cut lung slices
por: Tatler, Amanda L, et al.
Publicado: (2016) -
Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis
por: Habgood, Anthony N, et al.
Publicado: (2016) -
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020) -
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
por: May, James, et al.
Publicado: (2023) -
Pathobiology of Airway Remodeling in Asthma: The Emerging Role of Integrins
por: Joseph, Chitra, et al.
Publicado: (2022)